Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-27T12:16:00.911Z Has data issue: false hasContentIssue false
  • English
  • Français

Mastoid cavity obliteration using bone pâté versus bioactive glass granules in the management of chronic otitis media (squamous disease): a prospective comparative study

Published online by Cambridge University Press:  12 May 2021

A K Mishra ,
A Mallick ,
J R Galagali ,
A Gupta ,
A Sethi  and
A Ghotra
A K Mishra*
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
A Mallick
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
J R Galagali
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
A Gupta
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
A Sethi
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
A Ghotra
Affiliation:
Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi, India
*
Author for correspondence: Professor Awadhesh Kumar Mishra, Department of Otorhinolaryngology – Head Neck Surgery, Army College of Medical Sciences and Base Hospital, Delhi Cantt – 110010, India E-mail: [email protected] Fax: +91 11 2569 8691
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

To compare the efficacy of bone pâté versus bioactive glass in mastoid obliteration.

Method

This randomised parallel groups study was conducted at a tertiary care centre between September 2017 and August 2019. Sixty-eight patients, 33 males and 35 females, aged 12–56 years, randomly underwent single-stage canal wall down mastoidectomy with mastoid obliteration using either bone pâté (n = 35) or bioactive glass (n = 33), and were evaluated 12 months after the operation.

Results

A dry epithelised cavity (Merchant's grade 0 or 1) was achieved in 65 patients (95.59 per cent). Three patients (4.41 per cent) showed recidivism. The mean air–bone gap decreased to 16.80 ± 4.23 dB from 35.10 ± 5.21 dB pre-operatively. The mean Glasgow Benefit Inventory score was 30.02 ± 8.23. There was no significant difference between the two groups in these outcomes. However, the duration of surgery was shorter in the bioactive glass group (156.87 ± 7.83 vs 162.28 ± 8.74 minutes; p = 0.01).

Conclusion

The efficacy of both materials was comparable.

Keywords

Otitis MediaCholesteatomaMastoidectomyRecidivismInfection ControlQuality Of Life
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 135 , Issue 6 , June 2021 , pp. 492 - 500
Copyright
Copyright © The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Prof A K Mishra takes responsibility for the integrity of the content of the paper

References

Kuo, CL, Shiao, AS, Yung, M, Sakagami, M, Sudhoff, H, Wang, CH et al. Updates and knowledge gaps in cholesteatoma research. Biomed Res Int 2015;2015:854024CrossRefGoogle ScholarPubMed
Wormald, PJ, Nilssen, EL. The facial ridge and the discharging mastoid cavity. Laryngoscope 1998;108:92–6CrossRefGoogle ScholarPubMed
Wilkie, MD, Chudek, D, Webb, CJ, Panarese, A, Banhegyi, G. Canal wall down mastoidectomy with obliteration versus canal wall up mastoidectomy in primary cholesteatoma surgery. J Laryngol Otol 2019;133:1074–8CrossRefGoogle ScholarPubMed
Rajan, D, James, S. A prospective analysis of post mastoidectomy cavity complications. Int J Otorhinolaryngol Head Neck Surg 2019;5:1566–9CrossRefGoogle Scholar
Ghiasi, S. Mastoid cavity obliteration with combined Palva flap and bone pate. Iran J Otorhinolaryngol 2015;27:23–8Google ScholarPubMed
Walker, PC, Mowry, SE, Hansen, MR, Gantz, BJ. Long-term results of canal wall reconstruction tympanomastoidectomy. Otol Neurotol 2014;35:954–60CrossRefGoogle ScholarPubMed
Edfeldt, L, Stromback, K, Kinnefors, A, Rask-Andersen, H. Surgical treatment of adult cholesteatoma: long-term follow-up using total reconstruction procedure without staging. Acta Otolaryngol 2013;133:28–34CrossRefGoogle ScholarPubMed
Mokbel, KM, Khafagy, YW. Single flap with three pedicles, bone pate and split-thickness skin graft for immediate mastoid obliteration after canal wall down mastoidectomy. Eur Arch Otorhinolaryngol 2012;269:2037–41CrossRefGoogle ScholarPubMed
Deshmukh, S, Sharma, A, Dabholkar, J. Mastoid cavity obliteration: our experience. Otolaryngol Pol 2012;66:379–81CrossRefGoogle ScholarPubMed
Yung, M, Bennett, A. Use of mastoid obliteration techniques in cholesteatoma. Curr Opin Otolaryngol Head Neck Surg 2013;21:455–60CrossRefGoogle ScholarPubMed
Sarin, J, Grenman, R, Aitasalo, K, Pulkkinen, J. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol 2012;121:563–9CrossRefGoogle ScholarPubMed
Yorgancilar, E, Firat, U, Alabalik, U, Gun, R, Yildirim, M, Bakir, S et al. Is there epithelial tissue in bone pate? A histopathology study. Int Adv Otol 2012;8:366–70Google Scholar
Jones, JR. Review of bioactive glass: from Hench to hybrids. Acta Biomater 2013;23:S53–82CrossRefGoogle Scholar
Van Gestel, NA, Geurts, J, Hulsen, DJW, van Rietbergen, B, Hoffmann, S, Arts, JJ. Clinical applications of S53P4 bioactive glass in bone healing and osteomyelitic treatment: a literature review. Biomed Res Int 2015;2015:684826CrossRefGoogle ScholarPubMed
Silvola, JT. Mastoidectomy cavity obliteration with bioactive glass: a pilot study. Otolaryngol Head Neck Surg 2012;147:119–26CrossRefGoogle ScholarPubMed
Zhang, D, Lepparanta, O, Munukka, E, Ylanen, H, Viljanen, MK, Eerola, E et al. Antibacterial effects and dissolution behavior of six bioactive glasses. J Biomed Mater Res 2010;93:475–83Google ScholarPubMed
Bernardeschi, D, Pyatigorskaya, N, Russo, FY, De Seta, D, Corallo, G, Ferrary, E et al. Anatomical, functional and quality-of-life results for mastoid and epitympanic obliteration with bioactive glass s53p4: a prospective clinical study. Clin Otolaryngol 2017;42:387–96CrossRefGoogle ScholarPubMed
de Veij Mestdagh, PD, Colnot, DR, Borggreven, PA, Orelio, CC, Quak, JJ. Mastoid obliteration with S53P4 bioactive glass in cholesteatoma surgery. Acta Otolaryngol 2017;137:690–4CrossRefGoogle ScholarPubMed
Yung, M, Tassone, P, Moumoulidis, I, Vivekanandan, S. Surgical management of troublesome mastoid cavities. J Laryngol Otol 2011;125:221–6CrossRefGoogle ScholarPubMed
Stoor, P, Pulkkinen, J, Grénman, R. Bioactive glass S53P4 in the filling of cavities in the mastoid cell area in surgery for chronic otitis media. Ann Otol Rhinol Laryngol 2010;119:377–82CrossRefGoogle Scholar
Merchant, SN, Wang, P, Jang, CH, Glynn, RJ, Rauch, SD, McKenna, MJ et al. Efficacy of tympanomastoid surgery for control of infection in active chronic otitis media. Laryngoscope 1997;107:872–7CrossRefGoogle ScholarPubMed
American Academy of Otolaryngology-Head and Neck Foundation. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière disease. Otolaryngol Head Neck Surg 1995;113:181–5CrossRefGoogle Scholar
Kim, BG, Kim, HJ, Lee, SJ, Lee, E, Lee, SA, Lee, JD. Outcomes of modified canal wall down mastoidectomy and mastoid obliteration using autologous materials. Clin Exp Otorhinolaryngol 2019;12:360–6CrossRefGoogle ScholarPubMed
Pareschi, R, Lepera, D, Nucci, R. Canal wall down approach for tympano-mastoid cholesteatoma: long-term results and prognostic factors. Acta Otorhinolaryngol Ital 2019;39:122–9Google ScholarPubMed
Harris, AT, Mettias, B, Lesser, THJ. Pooled analysis of the evidence for open cavity, combined approach and reconstruction of the mastoid cavity in primary cholesteatoma surgery. J Laryngol Otol 2016;130:235–41CrossRefGoogle ScholarPubMed
Csakanyi, Z, Katona, G, Konya, D, Mohos, F, Sziklai, I. Middle ear gas pressure regulation: the relevance of mastoid obliteration. Otol Neurotol 2014;35:944–53CrossRefGoogle ScholarPubMed
Bernardeschi, D, Law-Ye, B, Bielle, F, Hochet, B, Sterkers, O, Dormont, D et al. Bioactive glass granules for mastoid and epitympanic surgical obliteration: CT and MRI appearance. Eur Radiol 2019;29:5617–26CrossRefGoogle ScholarPubMed
Robinson, K, Gatehouse, S, Browning, GG. Measuring patient benefit from otorhinolaryngological surgery and therapy. Ann Otol Rhinol Laryngol 1996;105:415–22CrossRefGoogle ScholarPubMed
Kurien, G, Greeff, K, Gomaa, N, Ho, A. Mastoidectomy and mastoid obliteration with autologous bone graft: a quality of life study. J Otolaryngol Head Neck Surg 2013;42:49CrossRefGoogle ScholarPubMed